MARTIJN KLEIJWEGT

Profile

First Name

: MARTIJN

Middle Name

:

Last Name

: KLEIJWEGT

Related Companies

Titles

Company Name

Related People

DIRECTOR

PASTEURIA BIOSCIENCE, INC.

FOUAD AZAAM, PH.D., TIMOTHY COCKSHUTT, DAVID N. DUNCAN, PH.D., AL KERN, RICHARD MOLLOY, JORG RIESMEIER, KELLY SMITH

DIRECTOR

PROSENSA HOLDING N.V.

GILES CAMPION, LUC DOCHEZ, DAAN ELLENS, GEORGES GEMAYEL, PETER GOODFELLOW, ANNALISA JENKINS, BERNDT MODIG, DAVID MOTT, HANS SCHIKAN, MICHAEL WYZGA

DIRECTOR

LIFE SCIENCES PARTNERS V C.V.

RENE ROBERT KUIJTEN, JOACHIM GUNTHER ROTHE

DIRECTOR

KIADIS PHARMA N.V.

SCOTT A. HOLMES, JAMES JOY, ARTHUR LAHR, BERNDT MODIG, SUBHANU SAXENA, MARK SCHAEFER, OTTO SCHWARZ, DR. ROBERT SOIFFER, MARK WEGTER

EXECUTIVE OFFICER

EQT HEALTH ECONOMICS 3 COOPERATIEF U.A.

FOUAD AZZAM, PATRIK BURNAS, RUDY DEKEYSER, N/A EQT FUND MANAGEMENT S.A R.L., N/A EQT HEALTH ECONOMICS 3 MANAGEMENT B.V., SARA HUDA, MERIJN KLAASSEN, RENE KUIJTEN, N/A LSP ADVISORY B.V., ANNE PORTWICH, JOACHIM ROTHE, MAGNUS SJOCRONA, CHRISTIAAN SNYDERS, PETER VELDMAN, MARK WEGTER

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

VENTURE CAPITAL FUND

DECLINE TO DISCLOSE

Equity

2024-01-05

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2019-06-05

D

VENTURE CAPITAL FUND

NOT APPLICABLE

2016-06-01

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

$5,000,001 - $25,000,000

Debt

2014-11-26

D

OTHER

DECLINE TO DISCLOSE

Debt

2010-08-24